Interaction of Local Anaesthetics with Histamine H1 Receptors in Guinea-pig Ileum

Horio, Shuhei; Nagare, Toshitaka; Ishida, Yoshiteru; Moritoki, Hideki

doi:10.1111/j.2042-7158.1997.tb06098.x

Cited by 6 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, procaine also affects the activity of Na,K-ATPase [81], an effect that can account for its antisickling properties [82]. Reports of procaine binding to dopamine [83], serotonin [84], muscarinic [85], nicotinic acetylcholine [86], opioid [87], and N-methyl-D-aspartate [88] receptors are also available. (4) is a class Ia antiarrhythmic drug used for shortterm treatment of ventricular tachycardia and a variety of supraventricular tachycardias, primarily atrial flutter and atrial fibrillation [89,90].…”

Section: -Diethylaminoethyl 4-aminobenzoate (Procaine)mentioning

confidence: 99%

Drug Evolution Concept in Drug Design: 2. Chimera Method

Roman¹,

Popek²,

Lazar³

et al. 2006

View full text Add to dashboard Cite

The drug evolution method represents a novel approach towards efficient rational drug design by implementing the drug evolution concept to the creation and development of general chemical libraries with the purpose of allowing the identification of drug candidates with improved odds and lesser costs than the traditional drug design strategies. As another example of successful translation of the biological evolution into chemical evolution, the chimera method comprises the grafting of selected building blocks, identified through a basic search within a drug library, onto the same substitution sites on a rationally chosen scaffold. The method allows the creation of a library containing both drugs and prospective drug candidates without any priorly required knowledge on the pursued disease or molecular target. Two libraries having scaffolds derived from para-aminobenzoic acid and salicylic acid have exemplified the application of the chimera method. The validation of the method has been achieved through the high number of recognized drugs within the library, which exhibit in the same time a wide variety of therapeutic activities and interact with a broad spectrum of molecular targets. The drug-enriched chimera libraries are expected to provide a highly efficient access to novel drug candidates whose unspecified therapeutic effects should be further revealed through high-throughput screening.

show abstract